HUTCHMED (China) (HCM) EBITDA (2015 - 2021)

HUTCHMED (China) (HCM) has 6 years of EBITDA data on file, last reported at -$62.8 million in Q4 2021.

• On a quarterly basis, EBITDA changed N/A year-over-year to -$62.8 million in Q4 2021; TTM through Dec 2021 was $449.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $102.8 million, down 16.0% from the prior year.
• EBITDA for Q4 2021 stood at -$62.8 million, down from $130.4 million in the prior quarter.
• Over the last five years, EBITDA for HCM reached as high as $220.6 million in Q1 2021 and fell as low as -$161.1 million in Q4 2018.
• Historically, EBITDA has averaged $26.5 million across 4 years, with a median of $14.8 million in 2018.
• Across the five-year window, EBITDA tumbled 343.04% in 2019 and jumped 269.04% in 2020, its largest moves.
• Year by year, EBITDA stood at -$161.1 million in 2018, then soared by 76.14% to -$38.4 million in 2019, then surged by 520.62% to $161.7 million in 2020, then tumbled by 138.82% to -$62.8 million in 2021.
• Per Business Quant data, the three most recent EBITDA figures were -$62.8 million in Q4 2021, $130.4 million in Q2 2021, and $220.6 million in Q1 2021.